Modern Companies Cannot Afford to Ignore the Digital Transformation
MANILA, Aug 5, 2022 – (ACN Newswire) – Digital transformation is an absolute necessity today….
News
Protolabs Reports Financial Results for the Second Quarter of 2022
Record Revenue of $126.9 million in the Second Quarter of 2022; GAAP Earnings Per Share…
Tutor Perini Reports Second Quarter 2022 Results
Strong operating cash flow of $58.0 million in Q2 2022 compared to usage of $84.6…
MediaTek and Unisoc Post Double-digit Shipment Growth in Smartphone Apps Processors
Qualcomm Increases Revenue Share BOSTON–(BUSINESS WIRE)–The global smartphone applications processor (AP) market grew 35 percent…
Saniona provides update on outstanding option programs
PRESS RELEASE August 5, 2022 Saniona (OMX: SANION), a clinical stage biopharmaceutical company, today announced…
Celyad Oncology Reports First Half 2022 Financial Results and Recent Business Highlights
Enrollment ongoing in Phase 1 dose-escalation IMMUNICY-1 trial for lead shRNA-based allogeneic CAR T candidate,…
ShibaDoge Team Announces SHIBDOGE Token
Milford, Delaware–(Newsfile Corp. – August 5, 2022) – The ShibaDoge team is excited to announce…
curaJOY Reveals Global Emotional Wellness Directory For Underserved Communities
curaJOY launches a free emotional wellness directory which gives marginalized communities access to global mental…
Florida Malware Regulation Compliance Consulting Service Updated by 2Secure Corp
As Florida adds more regulations to combat cyber threats, cybersecurity firm 2Secure Corp (646-560-5083) launches…
‘Gumball Dreams’ to have its International Premiere at the 79th Venice International Film Festival
LOS ANGELES, CA, Aug 5, 2022 – (ACN Newswire) – Internationally premiering at the 79th…
Sosei Heptares’ Oral, Selective M4 Receptor Agonist Advancing into Phase 2 Clinical Development under Multi-Program Collaboration with Neurocrine Biosciences
Neurocrine to conduct placebo-controlled Phase 2 study to investigate NBI-1117568 (formerly HTL-0016878) as a potential…
Axis Announces Amendments to 7.5% Extendible Unsecured Convertible Subordinated Debentures
TORONTO–(BUSINESS WIRE)–Axis Auto Finance Inc. (“Axis” or the “Company”) (TSX: AXIS), a rapidly growing financial…
Synovus Announces Pricing of $350 Million Senior Notes Offering
COLUMBUS, Ga.–(BUSINESS WIRE)–Synovus Financial Corp. (NYSE: SNV) today announced the pricing of its previously-announced underwritten…
RVL Pharmaceuticals plc Announces Insider and Athyrium-Led Financing
— Secured $68.9 million in committed financing through a combination of equity and non-dilutive debt…
Cue Biopharma Reports Second Quarter 2022 Financial Results
BOSTON, Aug. 04, 2022 (GLOBE NEWSWIRE) — Cue Biopharma, Inc. (Nasdaq: CUE), a clinical-stage biopharmaceutical…
Sigilon Therapeutics Reports Second Quarter 2022 Financial Results and Business Highlights
Company expects to report results of preclinical MPS-1 studies in second half of 2022 to…
Day One Reports Second Quarter 2022 Financial Results and Corporate Progress
Reported positive initial data from ongoing pivotal FIREFLY-1 study with tovorafenib (DAY101) in relapsed pediatric…
Cellectis Provides Business Update and Reports Financial Results for Second Quarter 2022
IND clearance received from FDA for UCART20x22 for the treatment of Non-Hodgkin Lymphoma Cellectis…
CytomX Therapeutics Reports Second Quarter 2022 Financial Results and Provides Business Update
– Recently-announced company restructuring focuses internal efforts on wholly-owned next-generation conditionally activated therapeutics, extending cash…
Generation Bio Reports Business Highlights and Second Quarter 2022 Financial Results
Cash balance of $312.2M expected to fund operations into 2025 CAMBRIDGE, Mass., Aug. 04, 2022…